DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Sangamo BioSciences, Inc. (SGMO)
« Back to company indexSGMO Chatter Timeline
Stock Ticker for SGMO
Most Active Tweeters for SGMO
| User | Tweets |
|---|---|
| @Gambiste1 | 18 |
| @Jaytanoo | 11 |
| @JustTradingHoy | 8 |
| @McBurnMark | 6 |
| @Biotech2050 | 6 |
Recent Tweets for SGMO
 |
@Gambiste1 RT @biopharmacaster: $sgmo going to 10+ shortly and will ride it to the data in a few weeks, 1000 shares at 9.77 June 26th 2019, 5:06pm |
 |
@biopharmacaster $sgmo going to 10+ shortly and will ride it to the data in a few weeks, 1000 shares at 9.77 June 26th 2019, 9:06am |
 |
@BehaviorFin $SGMO Which level sp must achieve In order for investors to believe in their platform and for institutional investo… https://t.co/m2BTLFNjdG June 26th 2019, 5:06am |
 |
@ConsumerFeed Wedbush Reiterates $11.00 Price Target for Sangamo Therapeutics $SGMO https://t.co/bX640IEHQN June 26th 2019, 3:06am |
 |
@SteinChaz @MLNardone @OpenOutcrier $sgmo July $10 calls had huge volume today and AH action not bad. June 25th 2019, 5:06pm |
|
@BehaviorFin @portefeuillefun $SGMO may be a buying opportunity priori to July 6th's results. Or not June 25th 2019, 3:06pm |
 |
@QuantchaIdeas Covered Call Alert: SANGAMO THERAPEUTICS INC. COMMON STOCK $SGMO returning up to 27.61% through 15-Nov-2019… https://t.co/YVh6p29W05 June 25th 2019, 11:06am |
 |
@AmericanBanking Sangamo Therapeutics Inc $SGMO Expected to Announce Quarterly Sales of $19.36 Million https://t.co/UR8ybyIfgx #stocks June 25th 2019, 2:06am |
 |
@TickerReport Sangamo Therapeutics $SGMO Given a $11.00 Price Target by Wedbush Analysts https://t.co/JVVJBvmScA June 25th 2019, 1:06am |
|
@Gambiste1 RT @semodough: $SGMO catalysts ahead 4Q19 (ASH) add'l SB-525 hemeA expansion cohort data; 4Q19 LT ST-400 ph.I/II beta-thal w/ add'l pts; 20… June 24th 2019, 3:06pm |
|
@Gambiste1 RT @jlpcoins: @chiragontwtr ? I’m just hoping they are not the next $SGMO in the making ? June 24th 2019, 3:06pm |
|
@Gambiste1 RT @dteb16: @semodough seems like fair amount of anticipation is building on $SGMO's #ISTH Hem A pres. if the data is strong and shows con… June 24th 2019, 3:06pm |
|
@Gambiste1 RT @semodough: JP $SGMO previews ph1/2 ALTA study of SB-525 in Hem A, expected at ISTH next week. expects the ISTH update next week to offe… June 24th 2019, 3:06pm |
 |
@BlueBioNow $SGMO Always amazed at the fools who short a stock in a powerful uptrend. Suicide. https://t.co/wG0tW0Fhou June 24th 2019, 1:06pm |
 |
@dteb16 @semodough seems like fair amount of anticipation is building on $SGMO's #ISTH Hem A pres. if the data is strong a… https://t.co/DscOsyQzI2 June 24th 2019, 1:06pm |
 |
@semodough JP $SGMO previews ph1/2 ALTA study of SB-525 in Hem A, expected at ISTH next week. expects the ISTH update next wee… https://t.co/MKSSWFOP51 June 24th 2019, 11:06am |
 |
@McBurnMark $SGMO @SangamoTx ?out @10.14, please make a great dive. June 24th 2019, 10:06am |
 |
@AnalystWire Sangamo BioSciences $SGMO Heading Into Meaningful Data Presentation, Wedbush Reiterates Neutral https://t.co/XRcgKWftfA June 24th 2019, 8:06am |
 |
@jlpcoins @chiragontwtr ? I’m just hoping they are not the next $SGMO in the making ? June 24th 2019, 5:06am |
 |
@njbankertrader RT @semodough: JEFF $SGMO guided to having hemeA (SB-525) follow-up data at ISTH (7/6 oral pres), which would have included 8 dose-escalati… June 23rd 2019, 10:06pm |
|
@semodough $SGMO catalysts ahead 4Q19 (ASH) add'l SB-525 hemeA expansion cohort data; 4Q19 LT ST-400 ph.I/II beta-thal w/ add'… https://t.co/eRDAvFakFm June 23rd 2019, 10:06pm |
|
@semodough JEFF $SGMO guided to having hemeA (SB-525) follow-up data at ISTH (7/6 oral pres), which would have included 8 dose… https://t.co/KZHt6GivhR June 23rd 2019, 10:06pm |
|
@Gambiste1 RT @biotech_junkie: @McBurnMark actually its July 5 (july 6 is australia time) so data release is on july 5 during trading hours $SGMO June 23rd 2019, 6:06pm |
|
@Gambiste1 RT @biotech_junkie: hearing rumor on $SGMO memory Tcells agains #diabetes per [email protected]_B_I_O_T_E_C_H_ might prevent diabetes in susceptible famil… June 23rd 2019, 6:06pm |
|
@Gambiste1 RT @JustTradingHoy: @rxptgh $SGMO had enough baby steps. With a low share price SGMO is giving a competitive advantage to its Gene Editing… June 23rd 2019, 6:06pm |
|
@njbankertrader RT @mchilberg: #Hemopholia A is shaping up to be a useful comparison of #Genetherapy and eventually pricing. Appears only $SGMO presenting… June 23rd 2019, 5:06pm |
 |
@mchilberg #Hemopholia A is shaping up to be a useful comparison of #Genetherapy and eventually pricing. Appears only $SGMO p… https://t.co/0crLzl9Vhu June 23rd 2019, 3:06pm |
 |
@biotech_junkie @McBurnMark actually its July 5 (july 6 is australia time) so data release is on july 5 during trading hours $SGMO June 23rd 2019, 3:06pm |
|
@biotech_junkie hearing rumor on $SGMO memory Tcells agains #diabetes per [email protected]_B_I_O_T_E_C_H_ might prevent diabetes in susceptible f… https://t.co/JfFzgA7aJQ June 23rd 2019, 3:06pm |
 |
@JustTradingHoy @rxptgh $SGMO had enough baby steps. With a low share price SGMO is giving a competitive advantage to its Gene Edit… https://t.co/8Dk81Zyq4n June 23rd 2019, 2:06pm |
|
@AmericanBanking Sangamo Therapeutics Inc $SGMO Expected to Announce Earnings of -$0.35 Per Share https://t.co/W3wva8D53u #stocks June 23rd 2019, 12:06pm |
 |
@MACDcurlingup Technically was ready to sell off, but announcement of SB-525 data update by $SGMO Friday moved sp higher. Should b… https://t.co/s2zST2Z2EC June 23rd 2019, 11:06am |
 |
@HottestStockNow $SGMO to reveal findings from early-stage study evaluating investigational SB-525 gene therapy in patients with sev… https://t.co/sTboNdMqzS June 22nd 2019, 1:06pm |
 |
@botpicks Should I Go Long or Short $SGMO ? June 22nd 2019, 9:06am |
 |
@Tickeron $SGMO Sangamo Therapeutics (SGMO, $9.95) was the market's top weekly gainer, with a +7% jump. Expect an Uptrend rev… https://t.co/fBSFIqMjh6 June 22nd 2019, 9:06am |
|
@Gambiste1 RT @McBurnMark: $SGMO @SangamoTx I care about its research data, but much more about its SP. So called solid data causes diving in SP ever… June 22nd 2019, 1:06am |
|
@McBurnMark $SGMO @SangamoTx I care about its research data, but much more about its SP. So called solid data causes diving in… https://t.co/MsqqYbWgl7 June 22nd 2019, 12:06am |
|
@Gambiste1 RT @JustTradingHoy: $SGMO ok amigos. Time for mid $20s. Is ridiculous that with all its partnerships, it doesn't trade at least where its i… June 21st 2019, 9:06pm |
|
@JustTradingHoy $SGMO ok amigos. Time for mid $20s. Is ridiculous that with all its partnerships, it doesn't trade at least where i… https://t.co/tmS4bHG9gS June 21st 2019, 8:06pm |
 |
@SwingTradeBot Outside Day today: $SGMO $SACH ... https://t.co/Ya1wmaeD73 June 21st 2019, 3:06pm |
 |
@GoGoBio RT @bigbluecup721: whytestocks: The Hot Zone: $SGMO News Article - Sangamo Announces Upcoming https://t.co/c7h3KcjMwZ June 21st 2019, 3:06pm |
 |
@bigbluecup721 whytestocks: The Hot Zone: $SGMO News Article - Sangamo Announces Upcoming https://t.co/c7h3KcjMwZ June 21st 2019, 12:06pm |
 |
@Aesculapius1898 RT @lipa0902: $SGMO will report data from additional patients. Total 8 patients data will be reported, in addition to the first 2 patients… June 21st 2019, 11:06am |
 |
@Michael06774565 @Michael06774565 $SGMO PLATFORM VALIDATED! More to come. June 21st 2019, 10:06am |
 |
@lipa0902 $SGMO will report data from additional patients. Total 8 patients data will be reported, in addition to the first 2… https://t.co/OZTJBuoVnW June 21st 2019, 10:06am |
|
@Aesculapius1898 RT @Jdalexander64: $SGMO $PFE ORAL SB-525 at ISTH to include longer-term follow-up data on 1st 8 patients including Factor VIII levels, BR,… June 21st 2019, 10:06am |
 |
@Jaytanoo $SGMO ITS OFFICIAL I HATE THIS STOCK June 21st 2019, 10:06am |
|
@McBurnMark @ebensteezin @SangamoTx nobody buy $SGMO stock is to prove $SGMO has good reseach data, to prove his own judgement… https://t.co/FlhCdeEOqh June 21st 2019, 10:06am |
 |
@Biotech2050 @Jdalexander64 $SGMO CEO always re-iterated that only meaningful data will be reported which means that the data fr… https://t.co/2znSy9ou3v June 21st 2019, 9:06am |
 |
@Jdalexander64 $SGMO $PFE ORAL SB-525 at ISTH to include longer-term follow-up data on 1st 8 patients including Factor VIII levels… https://t.co/2nixRaVglM June 21st 2019, 9:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.